Interestingly, our study detected activated PARP1 and phosphorylated α-Syn in PD models, while the administration of NBP also inhibited PARP1 activation and downregulated p-α-Syn levels, subsequently ameliorating neuronal apoptosis. The gene discussed is PARP1; the disease is Parkinson disease.